FR2870743B1 - USE OF ALKYL FURANS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF OBESITY AND FOR THE COSMETIC TREATMENT OF THE WEST OVERLOAD - Google Patents

USE OF ALKYL FURANS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF OBESITY AND FOR THE COSMETIC TREATMENT OF THE WEST OVERLOAD

Info

Publication number
FR2870743B1
FR2870743B1 FR0502758A FR0502758A FR2870743B1 FR 2870743 B1 FR2870743 B1 FR 2870743B1 FR 0502758 A FR0502758 A FR 0502758A FR 0502758 A FR0502758 A FR 0502758A FR 2870743 B1 FR2870743 B1 FR 2870743B1
Authority
FR
France
Prior art keywords
treatment
obesity
west
overload
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0502758A
Other languages
French (fr)
Other versions
FR2870743A1 (en
Inventor
Philippe Msika
Antoine Piccirilli
Nathalie Piccardi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Expanscience SA
Original Assignee
Laboratoires Expanscience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0502758A priority Critical patent/FR2870743B1/en
Application filed by Laboratoires Expanscience SA filed Critical Laboratoires Expanscience SA
Priority to PCT/FR2005/001312 priority patent/WO2005117857A1/en
Priority to EP05773033A priority patent/EP1750695B1/en
Priority to US11/597,634 priority patent/US7589121B2/en
Priority to PL05773033T priority patent/PL1750695T3/en
Priority to ES05773033T priority patent/ES2340510T3/en
Priority to CN2005800173724A priority patent/CN1960723B/en
Priority to MXPA06013885A priority patent/MXPA06013885A/en
Priority to AT05773033T priority patent/ATE462431T1/en
Priority to DE602005020274T priority patent/DE602005020274D1/en
Priority to JP2007514019A priority patent/JP4842260B2/en
Priority to CA2567479A priority patent/CA2567479C/en
Publication of FR2870743A1 publication Critical patent/FR2870743A1/en
Priority to HK07108349.4A priority patent/HK1100279A1/en
Priority to JP2011135366A priority patent/JP5405528B2/en
Application granted granted Critical
Publication of FR2870743B1 publication Critical patent/FR2870743B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR0502758A 2004-05-28 2005-03-21 USE OF ALKYL FURANS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF OBESITY AND FOR THE COSMETIC TREATMENT OF THE WEST OVERLOAD Active FR2870743B1 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR0502758A FR2870743B1 (en) 2005-03-21 2005-03-21 USE OF ALKYL FURANS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF OBESITY AND FOR THE COSMETIC TREATMENT OF THE WEST OVERLOAD
JP2007514019A JP4842260B2 (en) 2004-05-28 2005-05-27 Use of furan alkyls to produce drugs for the treatment of obesity and cosmetic treatment of overweight
US11/597,634 US7589121B2 (en) 2004-05-28 2005-05-27 Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
PL05773033T PL1750695T3 (en) 2004-05-28 2005-05-27 Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
ES05773033T ES2340510T3 (en) 2004-05-28 2005-05-27 USE OF RENTAL-FURANS FOR THE PREPARATION OF A MEDICINAL PRODUCT INTENDED FOR THE TREATMENT OF OBESITY AND FOR THE COSMETIC TREATMENT OF THE EXCEESS OF WEIGHT.
CN2005800173724A CN1960723B (en) 2004-05-28 2005-05-27 Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
MXPA06013885A MXPA06013885A (en) 2004-05-28 2005-05-27 Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight.
AT05773033T ATE462431T1 (en) 2004-05-28 2005-05-27 USE OF FURANALKYLENE FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF OBESITY AND COSMETIC TREATMENT OF OBESITY
PCT/FR2005/001312 WO2005117857A1 (en) 2004-05-28 2005-05-27 Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
EP05773033A EP1750695B1 (en) 2004-05-28 2005-05-27 Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
CA2567479A CA2567479C (en) 2004-05-28 2005-05-27 Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
DE602005020274T DE602005020274D1 (en) 2004-05-28 2005-05-27 USE OF FURANAL CYLINDERS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF ADIPOSITAS AND COSMETIC TREATMENT OF OVERWEIGHT
HK07108349.4A HK1100279A1 (en) 2004-05-28 2007-07-31 Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
JP2011135366A JP5405528B2 (en) 2004-05-28 2011-06-17 Use of furan alkyls to produce drugs for the treatment of obesity and cosmetic treatment of overweight

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0502758A FR2870743B1 (en) 2005-03-21 2005-03-21 USE OF ALKYL FURANS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF OBESITY AND FOR THE COSMETIC TREATMENT OF THE WEST OVERLOAD

Publications (2)

Publication Number Publication Date
FR2870743A1 FR2870743A1 (en) 2005-12-02
FR2870743B1 true FR2870743B1 (en) 2012-03-09

Family

ID=34978800

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0502758A Active FR2870743B1 (en) 2004-05-28 2005-03-21 USE OF ALKYL FURANS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF OBESITY AND FOR THE COSMETIC TREATMENT OF THE WEST OVERLOAD

Country Status (1)

Country Link
FR (1) FR2870743B1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468490A (en) * 1993-10-25 1995-11-21 Conkle & Olesten Lipidic furans useful for skin therapeutics
JP2000144170A (en) * 1998-09-01 2000-05-26 Janifu Tekku:Kk Substance having antiobestic function and action to reduce fat accumulated in internal organs and its use
FR2798667B1 (en) * 1999-09-22 2001-12-21 Pharmascience Lab PROCESS FOR THE EXTRACTION OF FURANIC COMPOUNDS AND POLYHYDROXYL FATTY ALCOHOLS FROM LAWYER, COMPOSITION BASED ON AND USE OF THESE COMPOUNDS IN THERAPEUTICS, COSMETICS AND FOOD
CA2735478C (en) * 2001-01-26 2014-07-08 Chugai Seiyaku Kabushiki Kaisha Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
US20030120073A1 (en) * 2001-04-25 2003-06-26 Seto Christopher T. Alpha-ketocarboxylic acid based inhibitors of phosphoryl tyrosine phosphatases
US20030144350A1 (en) * 2001-07-20 2003-07-31 Adipogenix, Inc. Fat accumulation-modulation compounds
FR2841470B1 (en) * 2002-06-27 2006-01-13 Pharmascience Lab USE OF ISOFLAVONES FOR THE PREPARATION OF TOPICAL COMPOSITIONS USEFUL FOR PROMOTING SLIMMING AND ASSOCIATED COSMETIC TREATMENT METHOD
FR2856294B1 (en) * 2003-06-18 2005-08-05 Expanscience Lab COSMETIC USE OF A COMPOSITION COMPRISING AT LEAST ONE OXAZOLIN AS AN ACTIVE INGREDIENT, AS SLIMMING AND / OR FOR PREVENTING AND / OR TREATING CELLULITE

Also Published As

Publication number Publication date
FR2870743A1 (en) 2005-12-02

Similar Documents

Publication Publication Date Title
FR2867778B1 (en) USE OF INDAZOLECARBOXAMIDE DERIVATIVES FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF MALARIA
FR20C1048I2 (en) Use of sodium deoxycholate for non-surgical fat removal
FR2854074B1 (en) USE OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
HUP0304051A3 (en) Furan and thiophene derivatives activating the human peroxisome proliferator activated receptors
FR2890306B1 (en) DEVICE FOR THE TREATMENT OF A VASCULAR POCKET
FR2903003B1 (en) USE OF A C-GLYCOSIDE DERIVATIVE TO ENHANCE THE BARRIER FUNCTION OF THE SKIN
FR2880888B1 (en) USE OF AMINODITHIOL AS A REDUCING AGENT FOR THE PERMANENT DEFORMATION OF HAIR
FR2930153B1 (en) USE OF A BAY EXTRACT, AND ESPECIALLY WOLFBERRY, FOR THE TREATMENT OF DROUGHT KERATINIC MATTER
FR2903902B1 (en) USE OF A COSMETIC COMPOSITION TO PROMOTE SKIN DEPIGMENTATION.
FR2930150B1 (en) USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR REGULATING THE POTASSIUM RATE IN BLOOD
FR2848844B1 (en) USE OF HYDROXYSTILENE ALKYL ETHER FOR THE TREATMENT OF DRY SKINS
FR2911507B1 (en) USE OF LIGNANS AND / OR FOR OBTAINING A PHARMACEUTICAL, COSMETIC, DERMATOLOGICAL AND / OR NEUTRACEUTICAL COMPOSITION
FR2870743B1 (en) USE OF ALKYL FURANS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF OBESITY AND FOR THE COSMETIC TREATMENT OF THE WEST OVERLOAD
FR2869539B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
FR2834887B1 (en) USE OF ARTEMIA EXTRACT FOR THE TREATMENT OF OLD SKIN
FR2886151B1 (en) USE OF COLCHICINE FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND / OR TREATMENT OF ENDOMETRIOSIS
FR2811224B1 (en) COSMETIC COMPOSITION FOR THE CARE OF SENSITIVE SKIN
FR2884716B1 (en) USE OF AZITHROMYCIN FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF OCULAR INFECTIONS
FR2870740B1 (en) USE OF ALKYL FURANS FOR THE COSMETIC TREATMENT OF CELLULITE
FR2916345B1 (en) DEVICE FOR THE TREATMENT OF THE REAGONMENT OF THE EYE
FR2872707B1 (en) CIRCULATORY ASSISTANCE DEVICE FOR THE HEART
FR2867946B1 (en) NOVEL INSECTICIDE COMPOSITION AND USE, IN PARTICULAR FOR THE IMPREGNATION OF MOSQUITO NETS
FR2883180B1 (en) USE OF ACETYL LEUCINE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF BALANCE DISORDERS
FR2927771B1 (en) MILK-BASED DIETETIC COMPOSITION AND ITS APPLICATION FOR THE TREATMENT OF PONDERAL OVERLOAD, OBESITY OR METABOLIC SYNDROME
FR2894144B1 (en) USE OF TYROSINE-ARGININE DIPEPTIDE IN A COSMETIC COMPOSITION OR FOR THE PREPARATION OF A MEDICINAL PRODUCT

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20